Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
“Pretreatment with pargyline , a potent inhibitor of monoamine oxidase (EC 1.4.3.4) abolishes the effects on 4-aminobutyric acid metabolism and potentiates the inhibitory effect of 5-hexyne-1.4-diamine on prostatic ornithine decarboxylase activity.”
“Abstract In mice, intraperitoneal administration of desipramine (12·5–100 mg/kg) or pargyline (25–200 mg/kg) reliably elevated the brain concentration of gamma-aminobutyric acid in a dose-dependent manner.”